Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

A nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing

Domain:

healthcare

Record type:

paper
Creator:
Verda RocWas
Publisher:
The
Host:avatar
Rationale: Standardized dosing of antitubercular drugs leads to variable plasma drug levels, which are associated with adverse drug reactions, delayed treatment response, and relapse. Mutations in genes affecting drug metabolism explain considerable interindividual pharmacokinetic variability; however, pharmacogenomic assays that predict metabolism of antitubercular drugs have been lacking. Objectives: We sought to develop a Nanopore sequencing panel and validate its performance in patients with active tuberculosis (TB) to personalize treatment dosing. Methods: We developed a Nanopore sequencing panel targeting 15 SNPs in five genes affecting the metabolism of antitubercular drugs. For validation, we sequenced DNA samples (n = 48) from the 1,000 Genomes Project and compared the variant calling accuracy with that of Illumina genome sequencing. We then sequenced DNA samples from patients with active TB (n = 100) from South Africa on a MinION Mk1C and evaluated the relationship between genotypes and pharmacokinetic parameters for isoniazid (INH) and rifampin (RIF). Measurements and Main Results: The pharmacogenomic panel achieved 100% concordance with Illumina sequencing in variant identification for the samples from the 1,000 Genomes Project. In the clinical cohort, coverage was more than 100× for 1,498 of 1,500 (99.8%) amplicons across the 100 samples. Thirty-three percent, 47%, and 20% of participants were identified as slow, intermediate, and rapid INH acetylators, respectively. INH clearance was 2.2 times higher among intermediate acetylators and 3.8 times higher among rapid acetylators, compared with slow acetylators (P < 0.0001). RIF clearance was 17.3% (2.50-29.9) lower in individuals with homozygous AADAC rs1803155 G→A substitutions (P = 0.0015). Conclusions: Targeted sequencing can enable the detection of polymorphisms that influence TB drug metabolism on a low-cost, portable instrument to personalize dosing for TB treatment or prevention.

Visit

doi.orgcrick.figshare.com

Tags

Infectious DiseaseGenetics &amp; Genomics

Licenses

Creative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcode

Similar

Nanopore sequencing for <i>Mycobacterium tuberculosis</i> drug susceptibility testing and outbreak investigationCost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active TuberculosisField evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and Zambia.Implementation of sequencing-based surveillance for drug-resistant tuberculosis in NigeriaSupplementary file 1_Implementation of sequencing-based surveillance for drug-resistant tuberculosis in Nigeria.docxONTdeCIPHER: an amplicon-based nanopore sequencing pipeline for tracking pathogen variants

Nanopore sequencing for <i>Mycobacterium tuberculosis</i> drug susceptibility testing and outbreak investigation

Abstract Background

Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis

Abstract Background There is marked interindividual variability in metabolism and resulting toxic

Field evaluation of nanopore targeted next-generation sequencing to predict drug-resistant tuberculosis from native sputum in South Africa and Zambia.

Rapid and comprehensive drug susceptibility testing (DST) is essential for diagnosing and treating d

Implementation of sequencing-based surveillance for drug-resistant tuberculosis in Nigeria

Sequencing for drug-resistant tuberculosis (DR-TB) surveillance was established in Nigeria for the f

Supplementary file 1_Implementation of sequencing-based surveillance for drug-resistant tuberculosis in Nigeria.docx

Sequencing for drug-resistant tuberculosis (DR-TB) surveillance was established in Nigeria for th

ONTdeCIPHER: an amplicon-based nanopore sequencing pipeline for tracking pathogen variants

International audience Motivation Amplicon-based nanopore sequencing is increasingly